Drug Profile
Research programme: recombinant interferon beta - Xencor
Alternative Names: Interferon beta variantsLatest Information Update: 29 Apr 2008
Price :
$50
*
At a glance
- Originator Xencor
- Class Interferons; Recombinant proteins
- Mechanism of Action Interferon beta stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Multiple sclerosis
Most Recent Events
- 25 Aug 2003 Preclinical trials in Multiple sclerosis in USA (unspecified route)